IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q4 2020 Holdings

Filed 2021-02-04 | 16 holdings | $288.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2021-02-05) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc (Bbio)(BBIO)COM10806X102$283.7M3,989,41298.5%
Aclaris Theraputics Inc (Acrs)(ACRS)COM00461U105$4.1M634,4551.4%
Eidos Therapeutics, Inc. (Eidix)(EIDXGBP)COM28249H104$147.8K1,123,6300.1%
Harmony Biosciences Hldgs in (Hrmy)(HRMY)COM413197104$30.5K842,8150.0%
Spruce Biosciences, Inc. (Sprb)COM85209E109$29.3K1,205,5110.0%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$22.8K1,025,0000.0%
Avrobio, Inc. (Avro)COM05455M100$14.1K1,009,7790.0%
Aeglea Biotherapeutics Inc (Agle)(AGLEUSD)COM00773J103$13.3K1,691,1510.0%
Poseida Therapeutics Inc (Pstx)(PSTXUSD)COM73730P108$11.4K1,043,2670.0%
Verona Pharma plc (Vrna)(VRNA)COM925050106$9.3K1,332,4850.0%
Atreca Inc (Bcel)(BCELUSD)CL A COM04965G109$6.3K387,6530.0%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$2.9K2,000,0000.0%
ObsEva SA (Obsv)COMH5861P103$2.9K1,386,3380.0%
Sunesis Pharmaceuticals, Inc. (Snss)COM867328700$2.0K1,010,0000.0%
Zosano Pharma Corporation (Zsan)COM98979H202$1.4K2,718,2260.0%
Nabriva Therapeutics plc (Nbrv)ASHSG63637105$462191,0280.0%